Services-Medical Laboratories
Standard Industrial Classification: SIC 8071
Industry Insider Sentiment Analysis
The Services-Medical Laboratories sector (SIC 8071) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-16 01:00 | 2022-12-13 | VCYT | VERACYTE, INC. | JONES EVAN/ FA | Director | SELL | $30.71 | 1,667 | $51,197 | 50,784 |
| 2022-12-15 00:30 | 2022-12-12 | BDSX | BIODESIX INC | SCHULER JACK W | Director, 10% owner | BUY | $1.48 | 100,000 | $148,380 | 20,052,112 |
| 2022-12-14 00:47 | 2022-12-09 | CELC | Celcuity Inc. | Sullivan Brian F. | Director, Officer, 10% owner | BUY | $5.75 | 260,869 | $1,499,997 | 3,016,643 |
| 2022-12-10 05:05 | 2022-12-07 | NTRA | Natera, Inc. | Chapman Steven Leonard | Director, Officer | OPT+S | $38.31 | 2,645 | $101,330 | 80,985 |
| 2022-12-09 17:00 | 2022-12-08 | XGN | EXAGEN INC. | ABALLI JOHN | Director, Officer | BUY | $2.68 | 90,000 | $241,200 | 440,000 |
| 2022-12-09 01:18 | 2022-12-06 | VCYT | VERACYTE, INC. | Kennedy Giulia C | Officer | SELL | $27.03 | 1,023 | $27,652 | 65,970 |
| 2022-12-08 00:11 | 2022-12-05 | CSTL | CASTLE BIOSCIENCES INC | MAETZOLD DEREK J | Director, Officer | SELL | $24.79 | 8,958 | $222,069 | 25,843 |
| 2022-12-07 00:50 | 2022-12-02 | PSNL | Personalis, Inc. | Chen Richard | Officer | SELL | $2.60 | 440 | $1,144 | 142,120 |
| 2022-12-07 00:54 | 2022-12-02 | PSNL | Personalis, Inc. | Tachibana Aaron | Officer | SELL | $2.60 | 4,360 | $11,336 | 218,015 |
| 2022-12-07 00:42 | 2022-12-02 | FLGT | Fulgent Genetics, Inc. | KIM PAUL | Officer | SELL | $35.33 | 653 | $23,070 | 223,403 |
| 2022-12-06 00:56 | 2022-12-01 | VCYT | VERACYTE, INC. | Anderson Bonnie H | Director, Officer | OPT+S | $28.26 | 80,000 | $2,260,752 | 65,003 |
| 2022-12-06 00:10 | 2022-12-01 | CSTL | CASTLE BIOSCIENCES INC | BRADBURY DANIEL | Director | SELL | $23.95 | 7,704 | $184,503 | 207,243 |
| 2022-12-06 00:40 | 2022-12-01 | DGX | QUEST DIAGNOSTICS INC | RING TIMOTHY M | Director | OPT+S | $152.50 | 2,025 | $308,813 | 24,149 |
| 2022-12-03 01:07 | 2022-11-30 | FLGT | Fulgent Genetics, Inc. | Xie Jian | Officer | SELL | $34.39 | 685 | $23,559 | 430,074 |
| 2022-12-02 00:48 | 2022-11-29 | CSTL | CASTLE BIOSCIENCES INC | Olson Tiffany | Director | BUY | $21.50 | 1,162 | $24,983 | 2,968 |
| 2022-11-30 00:35 | 2022-11-28 | DGX | QUEST DIAGNOSTICS INC | Doherty Catherine T. | Officer | OPT+S | $149.18 | 40,765 | $6,081,262 | 67,733 |
| 2022-11-24 00:10 | 2022-11-22 | CELC | Celcuity Inc. | Murphy Polly A. | Director | BUY | $9.68 | 5,000 | $48,383 | 5,000 |
| 2022-11-24 00:41 | 2022-11-21 | CSTL | CASTLE BIOSCIENCES INC | MAETZOLD DEREK J | Director, Officer | SELL | $20.76 | 8,958 | $185,941 | 26,218 |
| 2022-11-22 02:03 | 2022-11-21 | BDSX | BIODESIX INC | Watts Charles M | Director | BUY | $1.15 | 43,478 | $50,000 | 51,333 |
| 2022-11-22 02:02 | 2022-11-21 | BDSX | BIODESIX INC | Strobeck Matthew | Director | BUY | $1.15 | 2,669,562 | $3,069,996 | 2,135,076 |
| 2022-11-22 02:02 | 2022-11-21 | BDSX | BIODESIX INC | Kayyem Jon Faiz | Director | BUY | $1.15 | 173,913 | $200,000 | 173,913 |
| 2022-11-22 02:03 | 2022-11-21 | BDSX | BIODESIX INC | MASSARANY HANY | Director | BUY | $1.15 | 130,434 | $149,999 | 137,934 |
| 2022-11-22 02:03 | 2022-11-21 | BDSX | BIODESIX INC | PATIENCE JOHN | Director, 10% owner | BUY | $1.15 | 1,739,130 | $2,000,000 | 4,550,483 |
| 2022-11-22 02:03 | 2022-11-21 | BDSX | BIODESIX INC | SCHULER JACK W | Director, 10% owner | BUY | $1.15 | 8,695,652 | $10,000,000 | 19,952,112 |
| 2022-11-19 00:20 | 2022-11-16 | FLGT | Fulgent Genetics, Inc. | Xie Jian | Officer | SELL | $35.89 | 1,306 | $46,873 | 430,759 |
| 2022-11-19 00:12 | 2022-11-16 | FLGT | Fulgent Genetics, Inc. | Gao Hanlin | Officer | SELL | $35.89 | 342 | $12,275 | 906,585 |
| 2022-11-19 01:02 | 2022-11-16 | PSNL | Personalis, Inc. | Chen Richard | Officer | SELL | $2.71 | 1,295 | $3,509 | 142,560 |
| 2022-11-19 00:48 | 2022-11-16 | PSNL | Personalis, Inc. | Moore Stephen Michael | Officer | SELL | $2.71 | 2,045 | $5,542 | 90,440 |
| 2022-11-19 00:43 | 2022-11-16 | PSNL | Personalis, Inc. | Tachibana Aaron | Officer | SELL | $2.71 | 1,294 | $3,507 | 222,375 |
| 2022-11-19 00:13 | 2022-11-16 | FLGT | Fulgent Genetics, Inc. | KIM PAUL | Officer | SELL | $35.89 | 1,796 | $64,460 | 224,056 |
| 2022-11-18 01:46 | 2022-11-15 | GH | Guardant Health, Inc. | Kalia Kumud | Officer | SELL | $51.87 | 3,125 | $162,082 | 20,135 |
| 2022-11-16 01:02 | 2022-11-11 | VCYT | VERACYTE, INC. | Kennedy Giulia C | Officer | OPT+S | $29.34 | 2 | $59 | 68,001 |
| 2022-11-16 00:54 | 2022-11-11 | VCYT | VERACYTE, INC. | JONES EVAN/ FA | Director | SELL | $30.23 | 6,000 | $181,357 | 52,451 |
| 2022-11-10 16:40 | 2022-11-08 | LH | LABCORP HOLDINGS INC. | Schroeder Mark S | Officer | SELL | $232.67 | 1,116 | $259,660 | 6,687 |
| 2022-11-11 05:02 | 2022-11-09 | BDSX | BIODESIX INC | O'Kane Kieran | Officer | OPT+S | $1.03 | 1,705 | $1,758 | 15,184 |
| 2022-11-11 05:02 | 2022-11-09 | BDSX | BIODESIX INC | Georgantas Robert William III | Officer | OPT+S | $1.03 | 1,776 | $1,831 | 26,114 |
| 2022-11-11 05:02 | 2022-11-09 | BDSX | BIODESIX INC | Hutton Scott | Director, Officer | OPT+S | $1.03 | 13,777 | $14,205 | 106,010 |
| 2022-11-11 05:02 | 2022-11-09 | BDSX | BIODESIX INC | Cowie Robin Harper | Officer | OPT+S | $1.03 | 3,582 | $3,693 | 74,529 |
| 2022-11-11 05:02 | 2022-11-09 | BDSX | BIODESIX INC | Pestano Gary Anthony | Officer | OPT+S | $1.03 | 1,580 | $1,629 | 92,732 |
| 2022-11-11 05:02 | 2022-11-09 | BDSX | BIODESIX INC | Siurek Ryan H | Officer | OPT+S | $1.03 | 1,725 | $1,779 | 14,999 |
| 2022-11-10 00:09 | 2022-11-07 | CSTL | CASTLE BIOSCIENCES INC | MAETZOLD DEREK J | Director, Officer | SELL | $20.35 | 8,958 | $182,271 | 26,593 |
| 2022-11-09 01:44 | 2022-11-04 | VCYT | VERACYTE, INC. | Kennedy Giulia C | Officer | SELL | $25.00 | 1,023 | $25,575 | 68,001 |
| 2022-11-03 23:15 | 2022-11-01 | CSTL | CASTLE BIOSCIENCES INC | BRADBURY DANIEL | Director | SELL | $25.49 | 7,704 | $196,387 | 214,947 |
| 2022-11-02 23:32 | 2022-11-01 | DGX | QUEST DIAGNOSTICS INC | RING TIMOTHY M | Director | OPT+S | $144.06 | 2,000 | $288,120 | 24,149 |
| 2022-10-28 00:35 | 2022-10-26 | DGX | QUEST DIAGNOSTICS INC | DEPPE MICHAEL J | Officer | OPT+S | $145.00 | 15,497 | $2,247,065 | 32,013 |
| 2022-10-26 23:09 | 2022-10-24 | CSTL | CASTLE BIOSCIENCES INC | MAETZOLD DEREK J | Director, Officer | SELL | $20.46 | 8,958 | $183,319 | 26,967 |
| 2022-10-26 04:05 | 2022-10-24 | NTRA | Natera, Inc. | Sheena Jonathan | Director | OPT+S | $42.41 | 44 | $1,866 | 566,537 |
| 2022-10-26 04:05 | 2022-10-24 | NTRA | Natera, Inc. | RABINOWITZ DANIEL | Officer | OPT+S | $42.41 | 350 | $14,844 | 146,121 |
| 2022-10-26 04:05 | 2022-10-24 | NTRA | Natera, Inc. | Chapman Steven Leonard | Director, Officer | OPT+S | $42.41 | 905 | $38,381 | 73,326 |
| 2022-10-26 04:05 | 2022-10-24 | NTRA | Natera, Inc. | Brophy Michael Burkes | Officer | OPT+S | $42.41 | 2,488 | $105,517 | 89,326 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Services-Medical Laboratories sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (8071) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Services-Medical Laboratories
Every transaction in the Services-Medical Laboratories industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.